TG Therapeutics (TGTX) Shares Move Up from Lows Amid Amended GENUINE Phase 3 Protocol
- Wall Street dips as investors ready for Trump's inauguration
- Western Union (WU) Admits Anti-Money Laundering and Consumer Fraud Violations, Forfeits $586M in Settlement
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- Apple (AAPL) PT Raised to $140 at BofA/Merrill Lynch; iPhone 8 Will be 'Super-Long' Cycle
- Morgan Stanley Upgrades Tesla Motors (TSLA) to Overweight
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
TG Therapeutics (Nasdaq: TGTX) shares are seeing a slight rebound Thursday morning after the company announced an amended protocol for its GENUINE Phase 3 trial. The stock is down around 4 percent, but was 22 percent lower Wednesday night.
For more on the updated protocol, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla's (TSLA) Musk Says NHTSA's Final Report on Autopilot is 'Very Positive'
- Rockwell Collins (ROK) call put ratio 5 calls to 1 put into Q4
- Options with increasing volume
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!